Search research articles
Contact Us
Filters
Showing results (41-50 of 52) with videos related to
Page
of 6
Sort By:
BMC Neurology
|
April 1, 2025
Growth associated protein 43 (GAP-43) predicts brain amyloidosis in Alzheimer's dementia continuum: an [<sup>18</sup> F] AV-45 study
Rezvan Nemati, Ahmadreza Sohrabi-Ashlaghi, Parsa Saberian, et al.
Neuroscience
|
May 10, 2025
Elevated serum leucine levels are associated with cognitive impairment and reduced gray matter and cerebral volume across the Alzheimer's disease continuum
Hamide Nasiri, Ali Azargoonjahromi, Zahra Nouri, et al.
Metabolic Brain Disease
|
June 18, 2025
Amino acid patterns predict white matter integrity measures in the brain in patients across the Alzheimer's disease continuum
Farshad Goharmanesh, Maryam Masmoie, Hamide Nasiri, et al.
Neuroscience
|
November 8, 2025
Serum bile acids associated with brain hypometabolism in patients across the Alzheimer's disease continuum
Ali Shushtari, Kosar Shekari, Sina Rashti Mohammad, et al.
Molecular Neurobiology
|
July 16, 2025
Evaluating the Predictive Value of Oxylipins for Cognitive Measures and White Matter Hyperintensities in Alzheimer's Disease Continuum Compared to Conventional Beta‑amyloid and Tau Protein Biomarkers
Alireza Shaabanpoor Haghighi, Mahsa Mayeli, Elham Ramezannezhad, et al.
Molecular Neurobiology
|
September 30, 2025
Correction: Evaluating the Predictive Value of Oxylipins for Cognitive Measures and White Matter Hyperintensities in Alzheimer's Disease Continuum Compared to Conventional Beta‑amyloid and Tau Protein Biomarkers
Alireza Shaabanpoor Haghighi, Mahsa Mayeli, Elham Ramezannezhad, et al.
Archives of Gerontology and Geriatrics
|
August 3, 2024
Polygenic hazard score predicts synaptic and axonal degeneration and cognitive decline in Alzheimer's disease continuum
Mohammad-Erfan Farhadieh, Mehrdad Mozafar, Saameh Sanaaee, et al.
Scientific Reports
|
March 19, 2026
Associations between ventricular boundary shift integral and composite cognitive domains across the alzheimer's disease continuum
Hamide Nasiri, Hannaneh Azimizonuzi, Farbod Khosravi, et al.
IBRO Neuroscience Reports
|
January 19, 2026
Cardiovascular risk factors, aging, and incidence of dementia (CAIDE) risk score and its association with cognitive performance and volumetric brain measures in mild cognitive impairment
Yasaman Abtahi, Marjan Falahati, Sheyda Sharabiani, et al.
Biorxiv : the Preprint Server for Biology
|
November 24, 2025
Optimized reference region and the effect on test-retest reliability and detection of Parkinson's disease with [<sup>11</sup>C]UCB-J
Nikkita Khattar, David Matuskey, Jean-Dominique Gallezot, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 52) with videos related to
Sort By:
Page
of 6
BMC Neurology
|
April 1, 2025
Growth associated protein 43 (GAP-43) predicts brain amyloidosis in Alzheimer's dementia continuum: an [<sup>18</sup> F] AV-45 study
Rezvan Nemati, Ahmadreza Sohrabi-Ashlaghi, Parsa Saberian, et al.
Neuroscience
|
May 10, 2025
Elevated serum leucine levels are associated with cognitive impairment and reduced gray matter and cerebral volume across the Alzheimer's disease continuum
Hamide Nasiri, Ali Azargoonjahromi, Zahra Nouri, et al.
Metabolic Brain Disease
|
June 18, 2025
Amino acid patterns predict white matter integrity measures in the brain in patients across the Alzheimer's disease continuum
Farshad Goharmanesh, Maryam Masmoie, Hamide Nasiri, et al.
Neuroscience
|
November 8, 2025
Serum bile acids associated with brain hypometabolism in patients across the Alzheimer's disease continuum
Ali Shushtari, Kosar Shekari, Sina Rashti Mohammad, et al.
Molecular Neurobiology
|
July 16, 2025
Evaluating the Predictive Value of Oxylipins for Cognitive Measures and White Matter Hyperintensities in Alzheimer's Disease Continuum Compared to Conventional Beta‑amyloid and Tau Protein Biomarkers
Alireza Shaabanpoor Haghighi, Mahsa Mayeli, Elham Ramezannezhad, et al.
Molecular Neurobiology
|
September 30, 2025
Correction: Evaluating the Predictive Value of Oxylipins for Cognitive Measures and White Matter Hyperintensities in Alzheimer's Disease Continuum Compared to Conventional Beta‑amyloid and Tau Protein Biomarkers
Alireza Shaabanpoor Haghighi, Mahsa Mayeli, Elham Ramezannezhad, et al.
Archives of Gerontology and Geriatrics
|
August 3, 2024
Polygenic hazard score predicts synaptic and axonal degeneration and cognitive decline in Alzheimer's disease continuum
Mohammad-Erfan Farhadieh, Mehrdad Mozafar, Saameh Sanaaee, et al.
Scientific Reports
|
March 19, 2026
Associations between ventricular boundary shift integral and composite cognitive domains across the alzheimer's disease continuum
Hamide Nasiri, Hannaneh Azimizonuzi, Farbod Khosravi, et al.
IBRO Neuroscience Reports
|
January 19, 2026
Cardiovascular risk factors, aging, and incidence of dementia (CAIDE) risk score and its association with cognitive performance and volumetric brain measures in mild cognitive impairment
Yasaman Abtahi, Marjan Falahati, Sheyda Sharabiani, et al.
Biorxiv : the Preprint Server for Biology
|
November 24, 2025
Optimized reference region and the effect on test-retest reliability and detection of Parkinson's disease with [<sup>11</sup>C]UCB-J
Nikkita Khattar, David Matuskey, Jean-Dominique Gallezot, et al.
Page
of 6